Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Honoraria | $1,336 | 1 | 69.4% |
| Food and Beverage | $570.79 | 25 | 29.6% |
| Gift | $19.40 | 1 | 1.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| NATUS MEDICAL INCORPORATED | $1,336 | 1 | $0 (2023) |
| Horizon Therapeutics plc | $417.42 | 17 | $0 (2023) |
| Amgen Inc. | $44.01 | 2 | $0 (2024) |
| Sun Pharmaceutical Industries Inc. | $24.85 | 1 | $0 (2020) |
| TissueTech, Inc. | $21.99 | 1 | $0 (2017) |
| Carl Zeiss Meditec AG | $19.40 | 1 | $0 (2020) |
| Shire North American Group Inc | $17.02 | 1 | $0 (2018) |
| Aerie Pharmaceuticals, Inc. | $16.12 | 1 | $0 (2019) |
| Alcon Vision LLC | $15.13 | 1 | $0 (2023) |
| Spark Therapeutics, Inc. | $14.25 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $44.01 | 2 | Amgen Inc. ($44.01) |
| 2023 | $1,437 | 6 | NATUS MEDICAL INCORPORATED ($1,336) |
| 2022 | $175.60 | 10 | Horizon Therapeutics plc ($175.60) |
| 2021 | $15.38 | 1 | Horizon Therapeutics plc ($15.38) |
| 2020 | $184.63 | 4 | Horizon Therapeutics plc ($140.38) |
| 2019 | $30.37 | 2 | Aerie Pharmaceuticals, Inc. ($16.12) |
| 2018 | $17.02 | 1 | Shire North American Group Inc ($17.02) |
| 2017 | $21.99 | 1 | TissueTech, Inc. ($21.99) |
All Payment Transactions
27 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $21.86 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/21/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: TEPEZZA | ||||||
| 10/14/2023 | NATUS MEDICAL INCORPORATED | — | Honoraria | Cash or cash equivalent | $1,336.25 | General |
| 09/07/2023 | Alcon Vision LLC | HYDRUS Microstent (Device) | Food and Beverage | In-kind items and services | $15.13 | General |
| Category: Ophthalmology | ||||||
| 08/15/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $19.34 | General |
| Category: TEPEZZA | ||||||
| 04/20/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $26.12 | General |
| Category: TEPEZZA | ||||||
| 03/23/2023 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: TEPEZZA | ||||||
| 12/07/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $5.23 | General |
| Category: TEPEZZA | ||||||
| 11/17/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $22.61 | General |
| Category: TEPEZZA | ||||||
| 10/27/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $3.84 | General |
| Category: TEPEZZA | ||||||
| 10/12/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $28.84 | General |
| Category: TEPEZZA | ||||||
| 09/20/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $8.48 | General |
| Category: TEPEZZA | ||||||
| 09/14/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $24.41 | General |
| Category: TEPEZZA | ||||||
| 08/15/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $26.66 | General |
| Category: TEPEZZA | ||||||
| 07/13/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $22.56 | General |
| Category: TEPEZZA | ||||||
| 06/02/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $14.31 | General |
| Category: TEPEZZA | ||||||
| 04/27/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: TEPEZZA | ||||||
| 12/01/2021 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $15.38 | General |
| Category: TEPEZZA | ||||||
| 06/09/2020 | Carl Zeiss Meditec AG | None Specified (Medical Supply) | Gift | In-kind items and services | $19.40 | General |
| 03/03/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | Cash or cash equivalent | $124.99 | General |
| Category: TEPEZZA | ||||||
| 02/26/2020 | Sun Pharmaceutical Industries Inc. | CEQUA (Drug) | Food and Beverage | Cash or cash equivalent | $24.85 | General |
| Category: Ophthalmology | ||||||
| 02/19/2020 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $15.39 | General |
| Category: TEPEZZA | ||||||
| 10/23/2019 | Aerie Pharmaceuticals, Inc. | Rhopressa (Drug), Rocklatan | Food and Beverage | In-kind items and services | $16.12 | General |
| Category: Glaucoma | ||||||
| 09/25/2019 | Spark Therapeutics, Inc. | — | Food and Beverage | In-kind items and services | $14.25 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 323 | 418 | $183,141 | $29,361 |
| 2022 | 4 | 289 | 381 | $168,808 | $26,327 |
| 2021 | 4 | 298 | 370 | $132,579 | $26,280 |
| 2020 | 4 | 234 | 291 | $72,945 | $18,820 |
All Medicare Procedures & Services
16 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 93 | 106 | $61,904 | $9,656 | 15.6% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 129 | 195 | $54,600 | $9,030 | 16.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 53 | 53 | $40,333 | $6,283 | 15.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 48 | 64 | $26,304 | $4,392 | 16.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 87 | 104 | $60,736 | $9,173 | 15.1% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2022 | 115 | 175 | $49,000 | $7,980 | 16.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 49 | 49 | $37,289 | $5,471 | 14.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 38 | 53 | $21,783 | $3,702 | 17.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 99 | 111 | $47,884 | $9,831 | 20.5% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2021 | 119 | 169 | $43,470 | $7,753 | 17.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 42 | 42 | $26,471 | $5,598 | 21.1% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 38 | 48 | $14,754 | $3,098 | 21.0% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 74 | 80 | $22,800 | $6,815 | 29.9% |
| 92060 | Measurement of eye muscles to detect deviation of eyeball | Office | 2020 | 103 | 138 | $31,050 | $6,267 | 20.2% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2020 | 37 | 53 | $10,335 | $3,254 | 31.5% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 20 | 20 | $8,760 | $2,484 | 28.4% |
About Dr. Robert Gold, MD
Dr. Robert Gold, MD is a Ophthalmology healthcare provider based in Maitland, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1093753824.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Gold, MD has received a total of $1,926 in payments from pharmaceutical and medical device companies, with $44.01 received in 2024. These payments were reported across 27 transactions from 10 companies. The most common payment nature is "Honoraria" ($1,336).
As a Medicare-enrolled provider, Gold has provided services to 1,144 Medicare beneficiaries, totaling 1,460 services with total Medicare billing of $100,789. Data is available for 4 years (2020–2023), covering 16 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Other Specialties Pediatric Ophthalmology and Strabismus Specialist
- Location Maitland, FL
- Active Since 06/03/2006
- Last Updated 07/12/2018
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1093753824
Products in Payments
- TEPEZZA (Drug) $417.42
- TEPEZZA (Biological) $44.01
- CEQUA (Drug) $24.85
- Prokera (Device) $21.99
- None Specified (Medical Supply) $19.40
- XIIDRA (Drug) $17.02
- Rhopressa (Drug) $16.12
- HYDRUS Microstent (Device) $15.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Maitland
Dr. David Auerbach, Do, DO
Ophthalmology — Payments: $8,271
Richard Cohn, M.d, M.D
Ophthalmology — Payments: $5,044
Dr. Victor Thomas, Md, MD
Ophthalmology — Payments: $4,933
Dr. Kris-Ann Humphrey, M.d, M.D
Ophthalmology — Payments: $2,406
Dr. Andrew Schneier, M.d, M.D
Ophthalmology — Payments: $1,851
Dr. Jerry Shuster, Md, MD
Ophthalmology — Payments: $1,667